Cambridge, MA
OpenEvidence Information overload is a common problem in many high-value domains. It's a huge challenge in medicine. With such a rate of change, it is practically impossible for the world's physicians, medical scientists, and healthcare professionals to keep up with and comprehend all of the most recent research literature and clinical evidence pertinent to their work. Our contribution to the global effort to tame the medical information firehose is OpenEvidence: Artificial intelligence is applied in our strategy to aggregate, synthesize, and visualize clinical evidence in intelligible, clinically valuable formats that can be exploited.
openevidence.comThese are collections OpenEvidence is a part of. Click on the collection name to view similar companies.
Series C
$200,000,000
Series B
$210,000,000
Series A
$75,000,000
Seed
$27,000,000
Seed
$5,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on OpenEvidence.